Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Lacrimal stents are thin tubes that are implanted in patients with narrowed but not completely blocked tear ducts.
The top three companies, Beaver-Visitec International, Kaneka and FCI Ophthalmics, have 58% of the market share.
Market Analysis and Insights: Global Lacrimal Stent and Tube Systems Market
The global Lacrimal Stent and Tube Systems market is valued at US$ 37 million in 2019. The market size will reach US$ 49 million by the end of 2026, growing at a CAGR of 4.1% during 2021-2026.
Global Lacrimal Stent and Tube Systems Scope and Market Size
Lacrimal Stent and Tube Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lacrimal Stent and Tube Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Monocanalicular Stents
Bicanalicular Stents
The bicanalicular stents segment is expected to account for the larger share of 61% of the global market in 2019.
Segment by Application
Hospitals
Clinics
Other
Hospitals is expected to account for the largest share of 63% of the global market in 2019.
By Company
Beaver-Visitec International
Kaneka
Bess Medizintechnik GmbH
FCI Ophthalmics
Fruida
Sinopsys Surgical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
The top three companies, Beaver-Visitec International, Kaneka and FCI Ophthalmics, have 58% of the market share.
Market Analysis and Insights: Global Lacrimal Stent and Tube Systems Market
The global Lacrimal Stent and Tube Systems market is valued at US$ 37 million in 2019. The market size will reach US$ 49 million by the end of 2026, growing at a CAGR of 4.1% during 2021-2026.
Global Lacrimal Stent and Tube Systems Scope and Market Size
Lacrimal Stent and Tube Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lacrimal Stent and Tube Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
Monocanalicular Stents
Bicanalicular Stents
The bicanalicular stents segment is expected to account for the larger share of 61% of the global market in 2019.
Segment by Application
Hospitals
Clinics
Other
Hospitals is expected to account for the largest share of 63% of the global market in 2019.
By Company
Beaver-Visitec International
Kaneka
Bess Medizintechnik GmbH
FCI Ophthalmics
Fruida
Sinopsys Surgical
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
